| Authors: |
Telep LE; Gilead Sciences, Inc., Foster City, California, USA., Roulot DM; Liver Unit, Avicenne Hospital, AP-HP, Sorbonne Paris Nord University, Bobigny, France.; Inserm U955, Team 18, Paris-Est University, Créteil, France., Singer AW; Gilead Sciences, Inc., Foster City, California, USA., Stead AE; Gilead Sciences, Inc., Foster City, California, USA., Da BL; Gilead Sciences, Inc., Foster City, California, USA., Chee GM; Gilead Sciences, Inc., Foster City, California, USA., Kaiser EF; Costello Medical, Boston, Massachusetts, USA., Lee MD; Costello Medical, Boston, Massachusetts, USA., Reilly PS; Costello Medical, Boston, Massachusetts, USA., Chokkalingam AP; Gilead Sciences, Inc., Foster City, California, USA., Jacobson IM; NYU Grossman School of Medicine, New York University, New York, New York, USA. |
